藥房市場規模、佔有率及成長分析（按藥房、產品供應、可用性、藥物類型、藥物分子類型和地區）－2025-2032 年產業預測

預計 2023 年藥房市場規模將達到 1.5 兆美元，並從 2024 年的 1.58 兆美元成長到 2032 年的 2.45 兆美元，預測期內（2025-2032 年）的複合年成長率為 5.6%。

由於慢性病的增加、醫療保健需求的不斷成長以及製藥技術的進步，藥房市場正在迅速發展。關鍵成長要素包括個人化醫療需求的不斷成長、學名藥的普及以及網路藥局的擴張。然而，該行業面臨嚴格的監管、開發新藥成本高以及定價壓力等挑戰。儘管存在這些障礙，但受數位健康解決方案、遠端醫療服務以及預防性醫療保健需求不斷成長等機會的推動，藥房市場仍有望成長，尤其是在新興地區。總體而言，這種動態格局凸顯了創新和適應在競爭激烈的製藥領域取得成功的必要性。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 技術分析

藥局市場規模：依藥局分類

• 市場概覽
• 零售藥局
• 網路藥局
• 醫院藥房
• 其他藥局

藥局市場規模（依產品提供）

• 市場概覽
• 製藥
• 醫療設備
• 其他藥品

以庫存狀況分類的藥局市場規模

• 市場概覽
• 處方藥
• 非處方藥

藥品市場規模（依藥品類型分類）

• 市場概覽
• 品牌/專利藥品
• 學名藥

按藥物分子類型分類的藥房市場規模

• 市場概覽
• 小分子
• 生物製藥

按電子藥局平台類型分類的藥局市場規模

• 市場概覽
• 基於應用程式的平台
• 網路為基礎的平台

按治療領域分類的藥品市場規模

• 市場概覽
• 腫瘤疾病
• 心血管疾病
• 神經系統疾病
• 感染疾病
• 代謝紊亂
• 呼吸系統疾病
• 皮膚病
• 遺傳性疾病
• 自體免疫/發炎疾病
• 其他疾病

藥局市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• CVS Health Corporation（USA）
• AmerisourceBergen Corporation（USA）
• McKesson Corporation（USA）
• Cardinal Health, Inc.（USA）
• Rite Aid Corporation（USA）
• OptumRx, Inc.（USA）
• Humana Inc.（USA）
• Groupe Pharmagest SA（France）
• MedImpact Healthcare Systems, Inc.（USA）
• AllianceRx Walgreens Prime（USA）
• Benzer Pharmacy（USA）
• Kroger Health（USA）
• HealthWarehouse.com, Inc.（USA）

結論和建議

Pharmacy Market size was valued at USD 1.5 trillion in 2023 and is poised to grow from USD 1.58 trillion in 2024 to USD 2.45 trillion by 2032, growing at a CAGR of 5.6% during the forecast period (2025-2032).

The pharmacy market is rapidly evolving, driven by an increase in chronic illnesses, heightened healthcare demands, and advancements in pharmaceutical technology. Key growth factors include the rising need for personalized medicine, the proliferation of generic drugs, and the expansion of online pharmacies. However, the sector faces challenges such as stringent regulations, high R&D costs for new drug development, and pricing pressures. Despite these hurdles, the pharmacy market is poised for growth, fueled by opportunities in digital health solutions, telehealth services, and the rising demand for preventive care, especially in developing regions. Overall, this dynamic landscape underscores the need for innovation and adaptation to thrive in the competitive pharmacy sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Pharmacy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Pharmacy Market Segments Analysis

Global Pharmacy Market is segmented by Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of E-Pharmacy Platform, Therapeutic Area and region. Based on Pharmacy, the market is segmented into Retail Pharmacy, e-pharmacy, Hospital Pharmacy and Other Pharmacies. Based on Product Offered, the market is segmented into Drugs / Pharmaceuticals, Medical Devices and Other Pharmacy Products. Based on Availability, the market is segmented into Prescription Products and Over-the-counter Products. Based on Type of Drug, the market is segmented into Branded / Patented Drugs and Generic Drugs. Based on Type of Drug Molecule, the market is segmented into Small Molecules and Biologics. Based on Type of e-pharmacy Platform, the market is segmented into App-based Platforms and Web-based Platforms. Based on Therapeutic Area, the market is segmented into Oncological Disorders, Cardiovascular Disorders, Neurological Disorders, Infectious Diseases, Metabolic Disorders, Respiratory Disorders, Dermatological Disorders, Genetic Disorders, Autoimmune / Inflammatory Disorders and Other Disorders. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Pharmacy Market

Advancements in biotechnology are leading to an increased number of drug developments, particularly in the areas of biosimilars and biologics, which offer enhanced reliability and efficacy for various health conditions. Additionally, the rising significance of customized and personalized genetic information is influencing the demand for tailored medicines and products. These developments are driving significant growth within the pharmacy market, as healthcare providers and patients alike seek innovative solutions that cater to individual health needs, ultimately enhancing treatment outcomes and fostering a more personalized approach to medicine. Overall, these trends are transforming the landscape of the pharmacy sector.

Restraints in the Pharmacy Market

The pharmacy market faces significant constraints due to the high costs associated with developing and bringing new drugs to market, often amounting to millions or even billions of dollars. This financial burden tends to inhibit smaller companies from entering the market and effectively promoting their products. Additionally, a substantial number of drug candidates fail in clinical trials, resulting in considerable financial losses. These challenges collectively hinder the expansion and innovation within the pharmacy industry, as they disproportionately affect smaller players and deter investments needed for research and development. Consequently, the overall growth potential of the pharmacy market is restrained.

Market Trends of the Pharmacy Market

The pharmacy market is witnessing a significant trend towards personalized medicine, fueled by advancements in genomic testing and targeted therapies. This shift is particularly prominent in the management of chronic diseases and oncology, where individualized treatment plans can improve outcomes and enhance patient experiences. The rise of biosimilars and biologics further complements this trend by offering more effective and tailored treatment options for complex health conditions. As healthcare providers and patients increasingly prioritize customized therapies, the pharmacy sector must adapt to meet this growing demand, paving the way for innovative solutions and enhancing overall patient care in an evolving healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Analysis

Global Pharmacy Market Size by Pharmacy & CAGR (2025-2032)

• Market Overview
• Retail Pharmacy
• e-pharmacy
• Hospital Pharmacy
• Other Pharmacies

Global Pharmacy Market Size by Product Offered & CAGR (2025-2032)

• Market Overview
• Drugs / Pharmaceuticals
• Medical Devices
• Other Pharmacy Products

Global Pharmacy Market Size by Availability & CAGR (2025-2032)

• Market Overview
• Prescription Products
• Over-the-counter Products

Global Pharmacy Market Size by Type of Drug & CAGR (2025-2032)

• Market Overview
• Branded / Patented Drugs
• Generic Drugs

Global Pharmacy Market Size by Type of Drug Molecule & CAGR (2025-2032)

• Market Overview
• Small Molecules
• Biologics

Global Pharmacy Market Size by Type of e-pharmacy Platform & CAGR (2025-2032)

• Market Overview
• App-based Platforms
• Web-based Platforms

Global Pharmacy Market Size by Therapeutic Area & CAGR (2025-2032)

• Market Overview
• Oncological Disorders
• Cardiovascular Disorders
• Neurological Disorders
• Infectious Diseases
• Metabolic Disorders
• Respiratory Disorders
• Dermatological Disorders
• Genetic Disorders
• Autoimmune / Inflammatory Disorders
• Other Disorders

Global Pharmacy Market Size & CAGR (2025-2032)

• North America (Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e-pharmacy Platform, Therapeutic Area)
  • US
  • Canada
• Europe (Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e-pharmacy Platform, Therapeutic Area)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e-pharmacy Platform, Therapeutic Area)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e-pharmacy Platform, Therapeutic Area)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e-pharmacy Platform, Therapeutic Area)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• CVS Health Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AmerisourceBergen Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rite Aid Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OptumRx, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Humana Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Groupe Pharmagest S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedImpact Healthcare Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AllianceRx Walgreens Prime (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Benzer Pharmacy (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kroger Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HealthWarehouse.com, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations